Israel’s Brainstorm has announced positive final results from its phase 2a clinical trial of NurOwn cells in amyotrophic lateral sclerosis (ALS) patients used on 14 subjects at Hadassah Medical Center in Jerusalem. Nearly all subjects experienced clinical benefit.
http://www.brainstorm-cell.com/index.php/news-events/331-january-5-2015